in

Oral IL-23 Inhibitor Bests JAK Inhibitor in Psoriasis Trials

Source link : https://newshealth.biz/health-news/oral-il-23-inhibitor-bests-jak-inhibitor-in-psoriasis-trials/

A nonbiologic oral IL-23 inhibitor is more effective and safer than an approved oral JAK inhibitor for moderate-to-severe psoriasis in a head-to-head randomized trial. Medscape Medical News Source link : https://www.medscape.com/viewarticle/novel-oral-il-23-inhibitor-superior-jak-inhibitor-psoriasis-2025a1000ppj?src=rss Author : Publish date : 2025-09-25 13:35:00 Copyright for syndicated content belongs to the linked Source.

The post Oral IL-23 Inhibitor Bests JAK Inhibitor in Psoriasis Trials first appeared on News Health.

—-

Author : News Health

Publish date : 2025-09-25 13:35:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

The Dramatic Collapse of Mongolia’s Coalition Government

Unlock Your Future: Exciting Scholarship Opportunities Available Now